Digestimax
Digestimax, licence 80038448: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- FreeLife International Canada Corp.
- NPN or DIN-HM
- 80038448
- Status
- Inactive licence
- Licence date
- 21 December 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 27.72 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8250.0 FCC HUT | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Cellule entière | 44.34 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae | 44.34 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Cellule entière | 2550.0 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae | 2550.0 FCC DU | Not calculated |
| Mentha x piperita Source : Feuille | 2.5 mcl | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 0.25 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1687.5 FCC LU | Not calculated |
| papaïne Source : Carica papaya | 10.0 mg | Not calculated |
| papaïne Source : Feuille | 10.0 mg | Not calculated |
| papaïne Source : Carica papaya | 20000.0 FCC PU | Not calculated |
| papaïne Source : Feuille | 20000.0 FCC PU | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 43.72 mg | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 16.5 FCC AGU | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 17.31 mg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 6800.0 FCC HUT | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Maltodextrine, Gélatine, silice
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzymes. Digestive aid. Helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038448
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.